Inducible Knockdown of Endothelial Protein Tyrosine Phosphatase-1B Promotes Neointima Formation in Obese Mice by Enhancing Endothelial Senescence.


Journal

Antioxidants & redox signaling
ISSN: 1557-7716
Titre abrégé: Antioxid Redox Signal
Pays: United States
ID NLM: 100888899

Informations de publication

Date de publication:
01 03 2019
Historique:
pubmed: 2 2 2018
medline: 17 6 2020
entrez: 2 2 2018
Statut: ppublish

Résumé

Protein tyrosine phosphatase-1B (PTP1B) is a negative regulator of receptor tyrosine kinase signaling. In this study, we determined the importance of PTP1B expressed in endothelial cells for the vascular response to arterial injury in obesity. Morphometric analysis of vascular lesions generated by 10% ferric chloride (FeCl Our results reveal a previously unknown role of PTP1B in endothelial cells and provide mechanistic insights how PTP1B deletion or inhibition may promote endothelial senescence. Absence of PTP1B in endothelial cells impairs re-endothelialization, and the failure to induce smooth muscle cell quiescence or to protect from circulating growth factors may result in neointimal hyperplasia.

Identifiants

pubmed: 29390191
doi: 10.1089/ars.2017.7169
doi:

Substances chimiques

Chlorides 0
Chromans 0
Ferric Compounds 0
Tamoxifen 094ZI81Y45
PTPN1 protein, human EC 3.1.3.48
Protein Tyrosine Phosphatase, Non-Receptor Type 1 EC 3.1.3.48
Ptpn1 protein, mouse EC 3.1.3.48
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid S18UL9710X
ferric chloride U38V3ZVV3V

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

927-944

Auteurs

Marianne Jäger (M)

1 Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
2 Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Berlin, Germany.

Astrid Hubert (A)

1 Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.

Rajinikanth Gogiraju (R)

1 Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.

Magdalena L Bochenek (ML)

1 Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
2 Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Berlin, Germany.
3 Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.

Thomas Münzel (T)

1 Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
2 Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Berlin, Germany.

Katrin Schäfer (K)

1 Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
2 Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH